Horizon Pharma Looks to Tax Efficiency with Acquisition of Ireland’s Vidara Therapeutics
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 4 (Table of Contents)
Published: 21 Apr-2014
DOI: 10.3833/pdr.v2014.i4.2019 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Horizon Pharma has agreed to acquire Vidara Therapeutics via a reverse merger in a tax-driven deal valued at approximately US$660 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS